EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications

Rachel M Wake iD, Síle F Molloy, Joseph N Jarvis, Thomas S Harrison, Nelesh P Govender

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac675 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Rachel M Wake und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Infection and Immunity, St George's University of London, London, United Kingdom. Hauptthemen laut MEDLINE: Cryptococcus, HIV Infections, Meningitis, Cryptococcal. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Medical Research Council, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptococcal antigen (CrAg) is detectable in blood prior to the onset of symptomatic cryptococcal meningitis (CM), a leading cause of death among people with advanced human immunodeficiency virus (HIV) disease globally. Highly sensitive assays can detect CrAg in blood, and screening people with HIV with low CD4 counts, followed by preemptive antifungal treatment, is recommended and widely implemented as part of a global strategy to prevent CM and end cryptococcal-related deaths. Cryptococcal antigenemia encompasses a spectrum of conditions from preclinical asymptomatic infection (cerebrospinal fluid [CSF] CrAg-negative) through subclinical (CSF CrAg-positive without overt meningism) to clinical symptomatic cryptococcal disease, usually manifesting as CM. In this review, we summarize current understanding of the pathophysiology, risk factors for, and clinical implications of cryptococcal antigenemia within this spectrum. We also provide an update on global prevalence, recommended screening and treatment strategies, and future considerations for improving outcomes among patients with cryptococcal antigenemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptococcusHIV InfectionsMeningitis, CryptococcalHumansAntifungal AgentsAntigens, FungalHIVCD4 Lymphocyte Count

Stichwörter der Autor:innen

HIVacquired immunodeficiency syndromecryptococcal meningitiscryptococcosisdiagnostic screening programs

Substanzen

Antifungal AgentsAntigens, Fungal

Autor:innen und Institutionen

  • Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
  • Clinical Academic Group in Infection and Immunity, St George's University Hospitals National Health Service Foundation Trust, London, United Kingdom.
  • Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • MRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.

ORCID-Profile: Rachel M Wake

Förderung

  • NIH HHS
  • Medical Research Council
  • NIAID NIH HHS
  • Wellcome Trust
  • Health Education England
  • NIHR
  • Global Health
  • UK government

Zitieren

APA

Wake, R. M., Molloy, S. F., Jarvis, J. N., Harrison, T. S., & Govender, N. P. (2023). Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac675

Vancouver

Wake RM, Molloy SF, Jarvis JN, Harrison TS, Govender NP. Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac675

BibTeX
@article{Wake2023,
  author = {Wake, Rachel M and Molloy, Síle F and Jarvis, Joseph N and Harrison, Thomas S and Govender, Nelesh P},
  title = {Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac675}
}
Kostenlos starten →